Skip to main content
Top
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

TopBP1 contains transcriptional regulatory domains and regulates gene pathways involved in breast cancer

Authors: RHG Wright, ES Dornan, MM Donaldson, M MacFarlane, P Herzyk, IM Morgan

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

TopBP1 is a nuclear protein with eight BRCT domains and is involved in many aspects of nucleic acid metabolism: it is involved in the initiation of DNA replication in the Xenopus in vitro replication system by assisting loading of polymerase onto the replication complex; it is a substrate for ATM/ATR and is essential for the ATR DNA damage signalling pathway, and is also probably involved in the actual DNA repair process; it acts as a transcriptional cofactor for E2F1 where it regulates the apoptotic function of this protein. In addition, the yeast homologues of TopBP1, Dbp11 (Saccharomyces cerevisiae) and Cut5 (Schizo-saccharomyces pombe), are also involved in replication and repair processes. TopBP1 also shares functions with BRCA1; both are involved in regulating an intact G2/M checkpoint, they colocalise to sites of DNA damage, they share sequence homology (even outside the BRCT domains), they are substrates for ATM/ATR, and they can regulate expression of the c-myc gene. All of these properties of TopBP1 led to us investigating whether TopBP1 plays a role in breast cancer. …
Literature
1.
go back to reference Karppinen SM, Erkko H, Reini K, Pospiech H, Heikkinen K, Rapakko K, Syväoja JE, Winqvist R: Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer. Eur J Cancer. 2006, 42: 2647-2652. 10.1016/j.ejca.2006.05.030.CrossRefPubMed Karppinen SM, Erkko H, Reini K, Pospiech H, Heikkinen K, Rapakko K, Syväoja JE, Winqvist R: Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer. Eur J Cancer. 2006, 42: 2647-2652. 10.1016/j.ejca.2006.05.030.CrossRefPubMed
2.
go back to reference Going JJ, Nixon C, Dornan ES, Boner W, Donaldson MM, Morgan IM: Aberrant expression of TopBP1 in breast cancer. Histopathology. 2007, 50: 418-424. 10.1111/j.1365-2559.2007.02622.x.CrossRefPubMed Going JJ, Nixon C, Dornan ES, Boner W, Donaldson MM, Morgan IM: Aberrant expression of TopBP1 in breast cancer. Histopathology. 2007, 50: 418-424. 10.1111/j.1365-2559.2007.02622.x.CrossRefPubMed
3.
go back to reference Wright RH, Dornan ES, Donaldson MM, Morgan IM: TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains. Biochem J. 2006, 400: 573-582. 10.1042/BJ20060831.CrossRefPubMedPubMedCentral Wright RH, Dornan ES, Donaldson MM, Morgan IM: TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains. Biochem J. 2006, 400: 573-582. 10.1042/BJ20060831.CrossRefPubMedPubMedCentral
Metadata
Title
TopBP1 contains transcriptional regulatory domains and regulates gene pathways involved in breast cancer
Authors
RHG Wright
ES Dornan
MM Donaldson
M MacFarlane
P Herzyk
IM Morgan
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1905

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine